O	O	O	0	3	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	4	9	state	state	I-NP	NN	O	9	SUB	O
O	O	O	10	12	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	13	23	maturation	maturation	B-NP	NN	O	3	PMOD	O
O	O	O	24	26	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	27	36	monocytes	monocyte	B-NP	NNS	B-cell_type	5	PMOD	B-cell_type
O	O	O	37	41	into	into	B-PP	IN	O	4	NMOD	O
O	O	O	42	53	macrophages	macrophage	B-NP	NNS	B-cell_type	7	PMOD	B-cell_type
O	O	O	54	64	determines	determine	B-VP	VBZ	O	0	ROOT	O
O	O	O	65	68	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	69	76	effects	effect	I-NP	NNS	O	9	OBJ	O
O	O	O	77	79	of	of	B-PP	IN	O	11	NMOD	O
T1	B-Protein	B-Protein	80	82	IL	IL	B-NP	NN	B-protein	19	NMOD	B-protein
T1	I-Protein	I-Protein	82	83	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T1	I-Protein	I-Protein	83	84	4	4	I-NP	CD	I-protein	14	NMOD	I-protein
O	O	O	85	88	and	and	I-NP	CC	O	19	NMOD	O
T2	B-Protein	B-Protein	89	91	IL	IL	I-NP	NN	B-protein	19	NMOD	B-protein
T2	I-Protein	I-Protein	91	92	-	-	O	HYPH	I-protein	19	P	I-protein
T2	I-Protein	I-Protein	92	94	13	13	B-NP	CD	I-protein	12	PMOD	I-protein
O	O	O	95	97	on	on	B-PP	IN	O	11	NMOD	O
O	O	O	98	101	HIV	HIV	B-NP	NN	O	22	NMOD	O
O	O	O	102	113	replication	replication	I-NP	NN	O	20	PMOD	O
O	O	O	113	114	.	.	O	.	O	9	P	O

O	O	O	116	119	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	120	129	molecular	molecular	I-NP	JJ	O	3	NMOD	O
O	O	O	130	140	mechanisms	mechanism	I-NP	NNS	O	32	SUB	O
O	O	O	141	143	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	144	147	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	148	155	effects	effect	I-NP	NNS	O	4	PMOD	O
O	O	O	156	158	of	of	B-PP	IN	O	6	NMOD	O
T3	B-Protein	B-Protein	159	161	IL	IL	B-NP	NN	B-protein	14	NMOD	B-protein
T3	I-Protein	I-Protein	161	162	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T3	I-Protein	I-Protein	162	163	4	4	I-NP	CD	I-protein	9	NMOD	I-protein
O	O	O	164	167	and	and	I-NP	CC	O	14	NMOD	O
T4	B-Protein	B-Protein	168	170	IL	IL	I-NP	NN	B-protein	14	NMOD	B-protein
T4	I-Protein	I-Protein	170	171	-	-	O	HYPH	I-protein	14	P	I-protein
T4	I-Protein	I-Protein	171	173	13	13	B-NP	CD	I-protein	7	PMOD	I-protein
O	O	O	174	176	on	on	B-PP	IN	O	3	NMOD	O
O	O	O	177	180	HIV	HIV	B-NP	NN	O	17	NMOD	O
O	O	O	181	190	infection	infection	I-NP	NN	O	15	PMOD	O
O	O	O	191	193	in	in	B-PP	IN	O	17	NMOD	O
O	O	O	194	199	human	human	B-NP	JJ	B-cell_type	20	NMOD	B-cell_type
O	O	O	200	209	monocytes	monocyte	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	O	210	212	as	as	B-SBAR	IN	O	3	NMOD	O
O	O	O	213	217	they	they	B-NP	PRP	O	23	SUB	O
O	O	O	218	225	matured	mature	B-VP	VBD	O	21	SBAR	O
O	O	O	226	230	into	into	B-PP	IN	O	23	VMOD	O
O	O	O	231	239	monocyte	monocyte	B-NP	NN	B-cell_type	28	NMOD	B-cell_type
O	O	O	239	240	-	-	O	HYPH	O	25	P	O
O	O	O	240	247	derived	derive	B-VP	VBN	O	28	NMOD	O
O	O	O	248	259	macrophages	macrophage	B-NP	NNS	B-cell_type	24	PMOD	B-cell_type
O	O	O	260	264	over	over	B-PP	IN	O	23	VMOD	O
O	O	O	265	266	7	7	B-NP	CD	O	31	NMOD	O
O	O	O	267	271	days	day	I-NP	NNS	O	29	PMOD	O
O	O	O	272	276	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	277	289	investigated	investigate	I-VP	VBN	O	32	VC	O
O	O	O	290	295	using	use	B-VP	VBG	O	32	VMOD	O
O	O	O	296	299	HIV	HIV	B-NP	NN	O	46	NMOD	O
O	O	O	299	300	-	-	B-NP	HYPH	O	35	NMOD	O
O	O	O	300	301	1	1	I-NP	CD	O	36	NMOD	O
O	O	O	301	302	(	(	O	(	O	40	DEP	O
O	O	O	302	305	BaL	BaL	B-NP	NN	O	40	DEP	O
O	O	O	305	306	)	)	O	)	O	37	NMOD	O
O	O	O	306	307	,	,	O	,	O	46	P	O
O	O	O	308	311	and	and	O	CC	O	46	NMOD	O
O	O	O	312	315	low	low	B-NP	JJ	O	46	NMOD	O
O	O	O	316	323	passage	passage	I-NP	NN	O	46	NMOD	O
O	O	O	324	332	clinical	clinical	I-NP	JJ	O	46	NMOD	O
O	O	O	333	340	strains	strain	I-NP	NNS	O	34	OBJ	O
O	O	O	340	341	.	.	O	.	O	32	P	O

T5	B-Protein	B-Protein	342	344	IL	IL	B-NP	NN	B-protein	6	NMOD	B-protein
T5	I-Protein	I-Protein	344	345	-	-	I-NP	HYPH	I-protein	1	NMOD	I-protein
T5	I-Protein	I-Protein	345	346	4	4	I-NP	CD	I-protein	2	NMOD	I-protein
O	O	O	347	350	and	and	I-NP	CC	O	6	NMOD	O
T6	B-Protein	B-Protein	351	353	IL	IL	I-NP	NN	B-protein	6	NMOD	B-protein
T6	I-Protein	I-Protein	353	354	-	-	O	HYPH	I-protein	10	SUB	I-protein
T6	I-Protein	I-Protein	354	356	13	13	B-NP	CD	I-protein	6	NMOD	I-protein
O	O	O	357	359	up	up	B-ADVP	RB	O	9	VMOD	O
O	O	O	359	360	-	-	B-NP	HYPH	O	6	P	O
O	O	O	360	369	regulated	regulate	B-VP	VBD	O	0	ROOT	O
O	O	O	370	373	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	374	384	expression	expression	I-NP	NN	O	10	OBJ	O
O	O	O	385	387	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	388	392	both	both	O	CC	O	19	NMOD	O
O	O	O	393	400	genomic	genomic	B-NP	JJ	O	19	NMOD	O
O	O	O	401	404	and	and	I-NP	CC	O	19	NMOD	O
O	O	O	405	412	spliced	splice	I-NP	VBN	O	19	NMOD	O
O	O	O	413	416	HIV	HIV	I-NP	NN	B-RNA	19	NMOD	B-RNA
O	O	O	417	421	mRNA	mRNA	I-NP	NN	I-RNA	13	PMOD	I-RNA
O	O	O	422	424	in	in	B-PP	IN	O	12	NMOD	O
O	O	O	425	434	monocytes	monocyte	B-NP	NNS	B-cell_type	20	PMOD	B-cell_type
O	O	O	435	443	cultured	culture	B-VP	VBN	O	21	NMOD	O
O	O	O	444	446	on	on	B-PP	IN	O	22	VMOD	O
O	O	O	447	453	Teflon	Teflon	B-NP	NN	O	23	PMOD	O
O	O	O	453	454	,	,	O	,	O	10	P	O
O	O	O	455	457	as	as	B-SBAR	IN	O	10	VMOD	O
O	O	O	458	468	determined	determine	B-VP	VBN	O	26	SBAR	O
O	O	O	469	471	by	by	B-PP	IN	O	27	VMOD	O
O	O	O	472	480	Northern	Northern	B-NP	JJ	O	30	NMOD	O
O	O	O	481	489	analysis	analysis	I-NP	NN	O	34	NMOD	O
O	O	O	490	493	and	and	I-NP	CC	O	34	NMOD	O
T7	B-Protein	B-Protein	494	497	p24	p24	I-NP	NN	B-protein	33	NMOD	B-protein
T7	I-Protein	I-Protein	498	500	Ag	Ag	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	O	501	506	assay	assay	I-NP	NN	O	28	PMOD	O
O	O	O	506	507	.	.	O	.	O	10	P	O

O	O	O	508	513	Using	Use	B-VP	VBG	O	13	VMOD	O
O	O	O	514	515	a	a	B-NP	DT	O	4	NMOD	O
O	O	O	516	523	nuclear	nuclear	I-NP	JJ	O	4	NMOD	O
O	O	O	524	527	run	run	I-NP	NN	O	1	OBJ	O
O	O	O	527	528	-	-	B-ADVP	HYPH	O	1	VMOD	O
O	O	O	528	530	on	on	B-PP	IN	O	5	PMOD	O
O	O	O	531	536	assay	assay	B-NP	NN	O	6	PMOD	O
O	O	O	536	537	,	,	O	,	O	13	P	O
T8	B-Protein	B-Protein	538	540	IL	IL	B-NP	NN	B-protein	12	NMOD	B-protein
T8	I-Protein	I-Protein	540	541	-	-	I-NP	HYPH	I-protein	9	NMOD	I-protein
T8	I-Protein	I-Protein	541	542	4	4	I-NP	CD	I-protein	12	NMOD	I-protein
O	O	O	543	554	stimulation	stimulation	I-NP	NN	O	13	SUB	O
O	O	O	555	558	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	559	564	shown	show	I-VP	VBN	O	13	VC	O
O	O	O	565	567	to	to	I-VP	TO	O	16	VMOD	O
O	O	O	568	575	enhance	enhance	I-VP	VB	O	14	VMOD	O
O	O	O	576	589	transcription	transcription	B-NP	NN	O	16	OBJ	O
O	O	O	590	592	by	by	B-PP	IN	O	16	VMOD	O
O	O	O	593	596	two	two	B-NP	CD	O	18	PMOD	O
O	O	O	596	597	-	-	B-ADJP	HYPH	O	19	NMOD	O
O	O	O	598	600	to	to	B-PP	TO	O	20	VMOD	O
O	O	O	601	610	threefold	threefold	B-NP	RB	O	21	PMOD	O
O	O	O	610	611	.	.	O	.	O	13	P	O

T9	B-Protein	B-Protein	612	614	IL	IL	B-NP	NN	B-protein	12	NMOD	B-protein
T9	I-Protein	I-Protein	614	615	-	-	O	HYPH	I-protein	1	P	I-protein
T9	I-Protein	I-Protein	615	616	4	4	B-NP	CD	I-protein	1	NMOD	I-protein
O	O	O	617	627	stimulated	stimulate	B-VP	VBN	O	12	NMOD	O
T26	B-Entity	B-Entity	628	635	nuclear	nuclear	B-NP	JJ	B-protein	10	NMOD	B-protein
T26	I-Entity	I-Entity	636	642	factor	factor	I-NP	NN	I-protein	10	NMOD	I-protein
T26	I-Entity	I-Entity	642	643	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T26	I-Entity	I-Entity	643	649	kappaB	kappaB	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	O	650	657	nuclear	nuclear	I-NP	JJ	O	10	NMOD	O
O	O	O	658	671	translocation	translocation	I-NP	NN	O	12	NMOD	O
O	O	O	672	675	and	and	I-NP	CC	O	12	NMOD	O
O	O	O	676	683	binding	binding	I-NP	NN	O	0	ROOT	O
O	O	O	684	690	before	before	B-PP	IN	O	12	NMOD	O
O	O	O	691	702	enhancement	enhancement	B-NP	NN	O	13	PMOD	O
O	O	O	703	705	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	706	709	HIV	HIV	B-NP	NN	B-RNA	18	NMOD	B-RNA
O	O	O	710	713	RNA	RNA	I-NP	NN	I-RNA	18	NMOD	I-RNA
O	O	O	714	724	expression	expression	I-NP	NN	O	15	PMOD	O
O	O	O	724	725	.	.	O	.	O	12	P	O

O	O	O	726	736	Conversely	Conversely	B-ADVP	RB	O	13	VMOD	O
O	O	O	736	737	,	,	O	,	O	13	P	O
T10	B-Protein	B-Protein	738	740	IL	IL	B-NP	NN	B-protein	4	NMOD	B-protein
T10	I-Protein	I-Protein	740	741	-	-	B-NP	HYPH	I-protein	13	SUB	I-protein
T10	I-Protein	I-Protein	741	742	4	4	I-NP	CD	I-protein	4	NMOD	I-protein
O	O	O	743	746	and	and	I-NP	CC	O	13	VMOD	O
T11	B-Protein	B-Protein	747	749	IL	IL	I-NP	NN	B-protein	8	NMOD	B-protein
T11	I-Protein	I-Protein	749	750	-	-	B-NP	HYPH	I-protein	13	SUB	I-protein
T11	I-Protein	I-Protein	750	752	13	13	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	O	753	761	markedly	markedly	B-ADVP	RB	O	13	VMOD	O
O	O	O	762	765	and	and	I-ADVP	CC	O	10	AMOD	O
O	O	O	766	779	significantly	significantly	B-VP	RB	O	10	AMOD	O
O	O	O	780	789	inhibited	inhibit	I-VP	VBD	O	28	VMOD	O
O	O	O	790	793	HIV	HIV	B-NP	NN	O	15	NMOD	O
O	O	O	794	805	replication	replication	I-NP	NN	O	13	OBJ	O
O	O	O	806	808	at	at	B-PP	IN	O	13	VMOD	O
O	O	O	809	812	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	813	828	transcriptional	transcriptional	I-NP	JJ	O	19	NMOD	O
O	O	O	829	834	level	level	I-NP	NN	O	16	PMOD	O
O	O	O	835	837	in	in	B-PP	IN	O	13	VMOD	O
O	O	O	838	846	monocyte	monocyte	B-NP	NN	B-cell_type	24	NMOD	B-cell_type
O	O	O	846	847	-	-	O	HYPH	I-cell_type	24	NMOD	I-cell_type
O	O	O	847	854	derived	derive	B-VP	VBN	I-cell_type	24	NMOD	I-cell_type
O	O	O	855	866	macrophages	macrophage	B-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	O	866	867	,	,	O	,	O	28	P	O
O	O	O	868	871	and	and	O	CC	O	28	VMOD	O
O	O	O	872	876	this	this	B-NP	DT	O	28	SUB	O
O	O	O	877	885	occurred	occur	B-VP	VBD	O	0	ROOT	O
O	O	O	886	893	whether	whether	B-SBAR	IN	O	28	VMOD	O
O	O	O	894	899	these	these	B-NP	DT	O	31	NMOD	O
O	O	O	900	909	cytokines	cytokine	I-NP	NNS	B-protein	32	SUB	B-protein
O	O	O	910	914	were	be	B-VP	VBD	O	29	SBAR	O
O	O	O	915	920	added	add	I-VP	VBN	O	32	VC	O
O	O	O	921	927	before	before	B-PP	IN	O	33	VMOD	O
O	O	O	928	930	or	or	I-PP	CC	O	34	PMOD	O
O	O	O	931	936	after	after	I-PP	IN	O	34	PMOD	O
O	O	O	937	940	HIV	HIV	B-NP	NN	O	38	NMOD	O
O	O	O	941	950	infection	infection	I-NP	NN	O	34	PMOD	O
O	O	O	950	951	.	.	O	.	O	28	P	O

O	O	O	952	955	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	956	964	reversal	reversal	I-NP	NN	O	7	SUB	O
O	O	O	965	969	from	from	B-PP	IN	O	2	NMOD	O
O	O	O	970	981	stimulation	stimulation	B-NP	NN	O	3	PMOD	O
O	O	O	982	984	to	to	B-PP	TO	O	2	NMOD	O
O	O	O	985	995	inhibition	inhibition	B-NP	NN	O	5	PMOD	O
O	O	O	996	1004	occurred	occur	B-VP	VBD	O	0	ROOT	O
O	O	O	1005	1010	after	after	B-SBAR	IN	O	7	VMOD	O
O	O	O	1011	1012	3	3	B-NP	CD	O	11	AMOD	O
O	O	O	1013	1015	to	to	I-NP	TO	O	11	AMOD	O
O	O	O	1016	1017	5	5	I-NP	CD	O	12	NMOD	O
O	O	O	1018	1022	days	day	I-NP	NNS	O	8	PMOD	O
O	O	O	1023	1025	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	1026	1035	adherence	adherence	B-NP	NN	O	13	PMOD	O
O	O	O	1036	1038	to	to	B-PP	TO	O	14	NMOD	O
O	O	O	1039	1046	plastic	plastic	B-NP	NN	O	15	PMOD	O
O	O	O	1046	1047	.	.	O	.	O	7	P	O

T12	B-Protein	B-Protein	1048	1050	IL	IL	B-NP	NN	B-protein	4	SUB	B-protein
T12	I-Protein	I-Protein	1050	1051	-	-	O	HYPH	I-protein	1	NMOD	I-protein
T12	I-Protein	I-Protein	1051	1052	4	4	B-NP	CD	I-protein	1	NMOD	I-protein
O	O	O	1053	1056	had	have	B-VP	VBD	O	0	ROOT	O
O	O	O	1057	1059	no	no	B-NP	DT	O	7	NMOD	O
O	O	O	1060	1071	significant	significant	I-NP	JJ	O	7	NMOD	O
O	O	O	1072	1078	effect	effect	I-NP	NN	O	4	OBJ	O
O	O	O	1079	1081	on	on	B-PP	IN	O	4	VMOD	O
O	O	O	1082	1085	HIV	HIV	B-NP	NN	O	11	NMOD	O
O	O	O	1086	1093	reverse	reverse	I-NP	JJ	O	11	NMOD	O
O	O	O	1094	1107	transcription	transcription	I-NP	NN	O	8	PMOD	O
O	O	O	1107	1108	.	.	O	.	O	4	P	O

O	O	O	1109	1112	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	1113	1119	effect	effect	I-NP	NN	O	0	ROOT	O
O	O	O	1120	1122	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	1123	1127	both	both	B-NP	DT	O	5	NMOD	O
O	O	O	1128	1137	cytokines	cytokine	I-NP	NNS	B-protein	3	PMOD	B-protein
O	O	O	1138	1140	on	on	B-PP	IN	O	2	NMOD	O
O	O	O	1141	1144	the	the	B-NP	DT	O	6	PMOD	O
O	O	O	1145	1153	monocyte	monocyte	I-NP	NN	O	7	NMOD	O
O	O	O	1154	1164	maturation	maturation	I-NP	NN	O	29	SUB	O
O	O	O	1164	1165	/	/	O	SYM	O	29	P	O
O	O	O	1165	1180	differentiation	differentiation	B-NP	NN	O	29	SUB	O
O	O	O	1181	1182	(	(	O	(	O	19	DEP	O
T13	B-Protein	B-Protein	1182	1187	CD11b	CD11b	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	1187	1188	,	,	O	,	O	18	P	O
T14	B-Protein	B-Protein	1189	1193	CD13	CD13	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	1193	1194	,	,	O	,	O	18	P	O
O	O	O	1195	1198	and	and	O	CC	O	18	NMOD	O
T15	B-Protein	B-Protein	1199	1203	CD26	CD26	B-NP	NN	B-protein	19	DEP	B-protein
O	O	O	1203	1204	)	)	O	)	O	11	NMOD	O
O	O	O	1205	1208	and	and	O	CC	O	29	VMOD	O
O	O	O	1209	1214	other	other	B-NP	JJ	O	29	SUB	O
O	O	O	1215	1225	macrophage	macrophage	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	1226	1233	markers	marker	I-NP	NNS	I-protein	21	NMOD	I-protein
O	O	O	1234	1235	(	(	O	(	O	28	DEP	O
T16	B-Protein	B-Protein	1235	1239	CD14	CD14	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	1240	1243	and	and	O	CC	O	27	NMOD	O
T17	B-Protein	B-Protein	1244	1248	CD68	CD68	B-NP	NN	B-protein	28	DEP	B-protein
O	O	O	1248	1249	)	)	O	)	O	21	NMOD	O
O	O	O	1250	1253	was	be	B-VP	VBD	O	8	SBAR	O
O	O	O	1254	1262	examined	examine	I-VP	VBN	O	29	VC	O
O	O	O	1262	1263	.	.	O	.	O	2	P	O

T18	B-Protein	B-Protein	1264	1266	IL	IL	B-NP	NN	B-protein	4	SUB	B-protein
T18	I-Protein	I-Protein	1266	1267	-	-	I-NP	HYPH	I-protein	1	P	I-protein
T18	I-Protein	I-Protein	1267	1268	4	4	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	O	1269	1277	enhanced	enhance	I-NP	VBN	O	5	NMOD	O
T19	B-Protein	B-Protein	1278	1283	CD11b	CD11b	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	1283	1284	,	,	O	,	O	5	P	O
O	O	O	1285	1288	but	but	O	CC	O	14	NMOD	O
O	O	O	1289	1298	inhibited	inhibit	B-VP	VBD	O	10	NMOD	O
T20	B-Protein	B-Protein	1299	1303	CD26	CD26	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	1304	1314	expression	expression	I-NP	NN	O	14	NMOD	O
O	O	O	1315	1318	and	and	O	CC	O	14	NMOD	O
O	O	O	1319	1326	delayed	delay	B-NP	VBN	O	14	NMOD	O
T21	B-Protein	B-Protein	1327	1331	CD13	CD13	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	1332	1336	loss	loss	I-NP	NN	O	0	ROOT	O
O	O	O	1336	1337	.	.	O	.	O	14	P	O

T22	B-Protein	B-Protein	1338	1340	IL	IL	B-NP	NN	B-protein	4	SUB	B-protein
T22	I-Protein	I-Protein	1340	1341	-	-	O	HYPH	I-protein	1	P	I-protein
T22	I-Protein	I-Protein	1341	1343	13	13	B-NP	CD	I-protein	1	NMOD	I-protein
O	O	O	1344	1347	had	have	B-VP	VBD	O	0	ROOT	O
O	O	O	1348	1355	similar	similar	B-NP	JJ	O	6	NMOD	O
O	O	O	1356	1363	effects	effect	I-NP	NNS	O	4	OBJ	O
O	O	O	1364	1366	on	on	B-PP	IN	O	4	VMOD	O
T23	B-Protein	B-Protein	1367	1372	CD11b	CD11b	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	1373	1376	and	and	I-NP	CC	O	10	NMOD	O
T24	B-Protein	B-Protein	1377	1381	CD13	CD13	I-NP	NN	B-protein	7	PMOD	B-protein
O	O	O	1381	1382	,	,	O	,	O	4	P	O
O	O	O	1383	1386	but	but	O	CC	O	11	ROOT	O
O	O	O	1387	1389	no	no	B-NP	DT	O	14	NMOD	O
O	O	O	1390	1396	effect	effect	I-NP	NN	O	12	PRD	O
O	O	O	1397	1399	on	on	B-PP	IN	O	14	NMOD	O
T25	B-Protein	B-Protein	1400	1404	CD26	CD26	B-NP	NN	B-protein	15	PMOD	B-protein
O	O	O	1404	1405	.	.	O	.	O	12	P	O

O	O	O	1406	1411	Hence	Hence	B-ADVP	RB	O	5	VMOD	O
O	O	O	1411	1412	,	,	O	,	O	5	P	O
O	O	O	1413	1418	these	these	B-NP	DT	O	4	NMOD	O
O	O	O	1419	1428	cytokines	cytokine	I-NP	NNS	B-protein	5	SUB	B-protein
O	O	O	1429	1431	do	do	B-VP	VBP	O	0	ROOT	O
O	O	O	1432	1435	not	not	I-VP	RB	O	5	VMOD	O
O	O	O	1436	1442	simply	simply	I-VP	RB	O	5	VMOD	O
O	O	O	1443	1450	enhance	enhance	I-VP	VB	O	5	VC	O
O	O	O	1451	1459	monocyte	monocyte	B-NP	NN	O	10	NMOD	O
O	O	O	1460	1475	differentiation	differentiation	I-NP	NN	O	8	OBJ	O
O	O	O	1475	1476	,	,	O	,	O	5	P	O
O	O	O	1477	1480	but	but	O	CC	O	5	VMOD	O
O	O	O	1481	1485	have	have	B-VP	VBP	O	5	VMOD	O
O	O	O	1486	1493	complex	complex	B-NP	JJ	O	17	AMOD	O
O	O	O	1494	1497	and	and	I-NP	CC	O	17	AMOD	O
O	O	O	1498	1506	slightly	slightly	I-NP	RB	O	17	AMOD	O
O	O	O	1507	1516	divergent	divergent	I-NP	JJ	O	18	NMOD	O
O	O	O	1517	1524	effects	effect	I-NP	NNS	O	13	OBJ	O
O	O	O	1525	1529	that	that	B-NP	WDT	O	18	NMOD	O
O	O	O	1530	1536	impact	impact	B-VP	VBP	O	19	SBAR	O
O	O	O	1537	1539	on	on	B-PP	IN	O	20	VMOD	O
O	O	O	1540	1543	HIV	HIV	B-NP	NN	O	23	NMOD	O
O	O	O	1544	1555	replication	replication	I-NP	NN	O	21	PMOD	O
O	O	O	1556	1564	probably	probably	B-ADVP	RB	O	25	PMOD	O
O	O	O	1565	1572	through	through	B-PP	IN	O	20	VMOD	O
O	O	O	1573	1577	cell	cell	B-NP	NN	O	28	NMOD	O
O	O	O	1578	1587	signaling	signaling	I-NP	NN	O	28	NMOD	O
O	O	O	1588	1596	pathways	pathway	I-NP	NNS	O	34	NMOD	O
O	O	O	1597	1600	and	and	O	CC	O	34	NMOD	O
T27	B-Entity	B-Entity	1601	1608	nuclear	nuclear	B-NP	JJ	B-protein	34	NMOD	B-protein
T27	I-Entity	I-Entity	1609	1615	factor	factor	I-NP	NN	I-protein	34	NMOD	I-protein
T27	I-Entity	I-Entity	1615	1616	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
T27	I-Entity	I-Entity	1616	1622	kappaB	kappaB	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	O	1623	1636	translocation	translocation	I-NP	NN	O	25	PMOD	O
O	O	O	1636	1637	.	.	O	.	O	5	P	O
